tiprankstipranks
Trending News
More News >
Adtalem Global Education Inc (ATGE)
NYSE:ATGE

Adtalem Global Education (ATGE) AI Stock Analysis

Compare
351 Followers

Top Page

ATGE

Adtalem Global Education

(NYSE:ATGE)

Select Model
Select Model
Select Model
Outperform 79 (OpenAI - 4o)
Rating:79Outperform
Price Target:
$114.00
▲(10.02% Upside)
Adtalem Global Education's overall stock score is driven by strong financial performance and positive earnings call insights, highlighting robust enrollment and financial growth. The technical analysis presents mixed signals, while the valuation is reasonable. The company's strategic initiatives and share buyback program further enhance its investment appeal.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong demand for educational programs, enhancing market position and supporting long-term financial health.
Cash Flow Management
Strong cash flow generation supports ongoing operations and investments, ensuring financial stability and strategic flexibility.
Strategic Partnerships
Strategic partnerships enhance educational offerings, positioning the company to capitalize on industry trends and technological advancements.
Negative Factors
Chamberlain Enrollment Challenges
Enrollment challenges at Chamberlain University indicate potential weaknesses in marketing and operational execution, affecting growth prospects.
Post-Licensure Enrollment Softness
Ongoing enrollment softness in post-licensure programs could hinder revenue growth and impact the company's educational market share.
Leadership Transition
Leadership changes at Chamberlain University may disrupt strategic continuity and affect the institution's future growth and stability.

Adtalem Global Education (ATGE) vs. SPDR S&P 500 ETF (SPY)

Adtalem Global Education Business Overview & Revenue Model

Company DescriptionAdtalem Global Education Inc. provides workforce solutions worldwide. It operates through three segments, Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. This segment operates Chamberlain University. The Walden segment offers online certificates, bachelor's, master's, and doctoral degrees, including nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. This segment also operates Walden University. The Medical and Veterinary segment provides degree and non-degree programs in the medical and veterinary postsecondary education industry. This segment operates American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as DeVry Education Group Inc. and changed its name to Adtalem Global Education Inc. in May 2017. Adtalem Global Education Inc. was incorporated in 1987 and is based in Chicago, Illinois.
How the Company Makes MoneyAdtalem Global Education generates revenue primarily through tuition and fees paid by students enrolled in its educational programs. The company operates several institutions, including medical and nursing schools, which often charge higher tuition rates due to the specialized nature of their programs. Additionally, ATGE earns revenue from online education offerings, adult and continuing education programs, and professional certification courses. The company may also benefit from partnerships with employers looking to upskill their workforce, as well as government funding for education programs. Financial aid and federal student loans are significant factors in driving enrollment and, consequently, revenue for the company.

Adtalem Global Education Earnings Call Summary

Earnings Call Date:Oct 30, 2025
(Q1-2026)
|
% Change Since: |
Next Earnings Date:Feb 03, 2026
Earnings Call Sentiment Positive
The earnings call reflected strong overall performance with significant growth in enrollment and financial metrics, particularly at Walden University. However, challenges at Chamberlain with marketing and enrollment execution were noted as areas needing improvement. Despite these challenges, the company remains confident in its strategic direction and long-term growth prospects.
Q1-2026 Updates
Positive Updates
Record Enrollment Growth
Adtalem achieved its ninth consecutive quarter of enrollment growth, with total enrollment up 8% year-over-year to 97,000 students.
Revenue and Earnings Surge
Revenue increased by nearly 11% to $462 million, and adjusted earnings per share grew by 36% year-over-year to $1.75.
Walden University Milestone
Walden University reported its ninth consecutive quarter of enrollment growth at nearly 14%, achieving record total enrollment of over 52,000 students.
Strong Financial Position
Adtalem generated trailing 12-month free cash flow of $319 million, increased its revolving credit facility to $500 million, and extended its maturity.
Strategic Partnerships
New partnerships with Google Cloud and other organizations to prepare health care workers for an AI-enabled future.
Medical and Veterinary Segment Growth
Total enrollment in the Medical and Veterinary segment grew by 2.4% to approximately 5,300 students.
Negative Updates
Chamberlain Enrollment Challenges
Chamberlain's total enrollment grew by just over 2%, falling short of expectations due to marketing and enrollment operation execution failures.
Post-Licensure Enrollment Softness
Anticipated continued softness in post-licensure enrollment through the second and third quarters due to marketing and enrollment issues.
Company Guidance
In the first quarter of fiscal year 2026, Adtalem Global Education reported significant growth, with total enrollment increasing by 8% year-over-year to 97,000 students. Revenue rose nearly 11% to $462 million, and adjusted EBITDA margins expanded by 100 basis points. Adjusted earnings per share reached $1.75, reflecting a 36% year-over-year increase. Specific institutional highlights included Walden University's record enrollment growth of nearly 14% and Chamberlain University's 11th consecutive quarter of enrollment growth at 2.2%. The company maintained its full-year guidance, anticipating revenue between $1.9 billion and $1.94 billion and adjusted EPS ranging from $7.60 to $7.90. Despite execution challenges at Chamberlain, Adtalem remains confident in its strategic position and operational enhancements, including a partnership with Google Cloud to bolster AI credentials for healthcare professionals.

Adtalem Global Education Financial Statement Overview

Summary
Adtalem Global Education demonstrates strong financial health with consistent revenue and profit growth, efficient operational management, and a stable financial position. The company shows robust profitability margins and healthy cash flow generation, supporting ongoing operations and investments.
Income Statement
85
Very Positive
Adtalem Global Education shows strong financial performance with consistent revenue growth, highlighted by a 2.51% increase in the TTM period. The company maintains healthy profitability margins, including a gross profit margin of 58.51% and a net profit margin of 13.74%. The EBIT and EBITDA margins are also robust at 19.96% and 23.50%, respectively, indicating efficient operational management.
Balance Sheet
78
Positive
The balance sheet reflects a stable financial position with a manageable debt-to-equity ratio of 0.53, showing prudent leverage. Return on equity is strong at 17.49%, indicating effective use of shareholder funds. The equity ratio stands at 50.82%, suggesting a solid capital structure with a good proportion of assets financed by equity.
Cash Flow
82
Very Positive
Cash flow analysis reveals a positive trajectory with a 12.42% growth in free cash flow in the TTM period. The operating cash flow to net income ratio is 0.66, and the free cash flow to net income ratio is 0.85, both indicating healthy cash generation relative to earnings. This suggests strong cash flow management and the ability to support ongoing operations and investments.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.83B1.79B1.58B1.45B1.38B899.25M
Gross Profit1.07B1.02B886.10M802.34M722.07M441.34M
EBITDA444.41M397.67M346.96M328.95M297.42M182.75M
Net Income251.96M237.06M136.78M93.36M310.99M70.03M
Balance Sheet
Total Assets2.87B2.75B2.74B2.81B3.03B3.08B
Cash, Cash Equivalents and Short-Term Investments279.69M213.96M234.40M287.57M365.74M1.32B
Total Debt775.95M774.00M847.85M896.19M1.07B1.29B
Total Liabilities1.41B1.32B1.37B1.35B1.54B1.78B
Stockholders Equity1.46B1.43B1.37B1.46B1.49B1.30B
Cash Flow
Free Cash Flow323.20M287.57M246.88M165.90M-20.45M143.53M
Operating Cash Flow379.13M337.90M295.77M191.91M10.60M192.20M
Investing Cash Flow-48.41M-41.92M-47.85M23.74M-551.80M-56.69M
Financing Cash Flow-331.41M-316.02M-301.80M-288.51M-424.48M676.47M

Adtalem Global Education Technical Analysis

Technical Analysis Sentiment
Negative
Last Price103.62
Price Trends
50DMA
110.58
Negative
100DMA
123.14
Negative
200DMA
119.01
Negative
Market Momentum
MACD
-1.50
Negative
RSI
56.65
Neutral
STOCH
84.09
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ATGE, the sentiment is Negative. The current price of 103.62 is above the 20-day moving average (MA) of 95.23, below the 50-day MA of 110.58, and below the 200-day MA of 119.01, indicating a neutral trend. The MACD of -1.50 indicates Negative momentum. The RSI at 56.65 is Neutral, neither overbought nor oversold. The STOCH value of 84.09 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ATGE.

Adtalem Global Education Risk Analysis

Adtalem Global Education disclosed 45 risk factors in its most recent earnings report. Adtalem Global Education reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Adtalem Global Education Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$3.65B15.4217.38%12.24%52.97%
75
Outperform
$4.81B6.5917.20%0.65%4.13%228.37%
74
Outperform
$4.64B22.6727.77%7.05%-2.63%
73
Outperform
$1.89B16.736.76%2.99%3.74%-8.40%
73
Outperform
$4.99B24.7720.15%2.01%-13.82%
72
Outperform
$1.89B12.5316.14%1.90%24.23%17.56%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ATGE
Adtalem Global Education
103.62
12.56
13.79%
PRDO
Perdoceo Education
29.73
3.64
13.95%
LOPE
Grand Canyon Education
168.00
5.06
3.11%
STRA
Strategic Education
80.28
-10.84
-11.90%
GHC
Graham Holdings
1,111.03
231.73
26.35%
LAUR
Laureate Education
33.44
15.02
81.54%

Adtalem Global Education Corporate Events

Stock BuybackBusiness Operations and Strategy
Adtalem Announces New $750M Share Buyback Program
Positive
Dec 15, 2025

On December 15, 2025, Adtalem Global Education announced the completion of a $150 million share repurchase program and the authorization of a new $750 million share repurchase initiative, set to run through December 2028. This move reflects the company’s confidence in its strategic direction and financial strength, allowing it to invest in growth opportunities while returning capital to shareholders. Since February 2022, Adtalem has returned $913 million to shareholders and reduced its debt significantly, demonstrating robust operational execution and financial management.

Executive/Board Changes
Adtalem Announces Retirement of Chamberlain University President
Neutral
Oct 7, 2025

On October 6, 2025, Adtalem Global Education announced the retirement of Dr. Karen Cox, President of Chamberlain University, after nearly 40 years in healthcare and nursing education. Under her leadership since 2018, Chamberlain University became the largest school of nursing in the U.S., significantly expanding its student base and strengthening its position as a leading grantor of Bachelor of Science in Nursing degrees. The company has initiated an external search for her successor, highlighting the impact of her tenure on the institution’s growth and commitment to academic excellence.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 19, 2025